ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 010,77
0,22%
Dow Jones
38 686,32
1,51%
DAX
18 598,69
0,63%
Brent Oil
81,155
0,43%
Bitcoin
69 000,67
1,85%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Athersys Inc (ATHX)

  7. Athersys Inc (ATHX) Actualités

ATHX

Athersys (ATHX)

Athersys Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ATHX
DateHeureSourceTitreSymboleSociété
08/01/202413h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
21/12/202317h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
16/11/202314h35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATHXAthersys Inc
16/10/202322h52Business WireAthersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic AlternativesNASDAQ:ATHXAthersys Inc
10/10/202314h30Business WireAthersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with HealiosNASDAQ:ATHXAthersys Inc
03/10/202322h30Business WireAthersys Licenses its Animal Health Assets to Ardent Animal HealthNASDAQ:ATHXAthersys Inc
02/10/202323h04Business WireAthersys Director Jane Wasman Appointed Board ChairNASDAQ:ATHXAthersys Inc
25/09/202322h36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATHXAthersys Inc
22/09/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ATHXAthersys Inc
19/09/202303h35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ATHXAthersys Inc
14/09/202316h41Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
13/09/202323h13Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ATHXAthersys Inc
06/09/202320h45Business WireGrant Awarded to Newcastle University to Research Athersys’ MultiStem® in Machine Perfusion Prior to Kidney TransplantationNASDAQ:ATHXAthersys Inc
21/08/202320h36Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ATHXAthersys Inc
18/08/202303h30Business WireAthersys, Inc. Announces Pricing of $3.5 Million Public OfferingNASDAQ:ATHXAthersys Inc
17/08/202322h15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ATHXAthersys Inc
16/08/202323h01Business WireAthersys Reports Second Quarter 2023 Financial Results and Business HighlightsNASDAQ:ATHXAthersys Inc
11/08/202314h00Business WireAthersys Appoints Neema Mayhugh, PhD to its Board of DirectorsNASDAQ:ATHXAthersys Inc
07/08/202323h02Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ATHXAthersys Inc
31/07/202319h38Business WireAthersys to Host Business Update Conference Call on August 9thNASDAQ:ATHXAthersys Inc
14/07/202322h31Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ATHXAthersys Inc
14/07/202322h16Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ATHXAthersys Inc
28/06/202312h00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATHXAthersys Inc
08/06/202316h29Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ATHXAthersys Inc
08/06/202312h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ATHXAthersys Inc
01/06/202322h40Business WirePatient Enrollment Begins in Third and Final Cohort of the Phase 2 MATRICS-1 Clinical Study Evaluating Athersys’ MultiStem® Following Hemorrhagic TraumaNASDAQ:ATHXAthersys Inc
26/05/202323h31Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ATHXAthersys Inc
23/05/202314h30Business WireAthersys Restructures Debt with SupplierNASDAQ:ATHXAthersys Inc
18/05/202315h58Business WireAthersys Reports First Quarter 2023 Financial Results and Business HighlightsNASDAQ:ATHXAthersys Inc
15/05/202322h54Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ATHXAthersys Inc
 Showing the most relevant articles for your search:NASDAQ:ATHX

Dernières Valeurs Consultées

BIT
AGL
Autogrill
BOV
CMIG4
CEMIG PN
BIT
GS0127
Goldman Sachs
BIT
UB7HQK
Unicredit Bank
AQSE
PHP.GB
Primary Health Prop
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés